IL93959A0 - Pharmaceutical compositions comprising biologically active peptides and an antibiotic - Google Patents

Pharmaceutical compositions comprising biologically active peptides and an antibiotic

Info

Publication number
IL93959A0
IL93959A0 IL93959A IL9395990A IL93959A0 IL 93959 A0 IL93959 A0 IL 93959A0 IL 93959 A IL93959 A IL 93959A IL 9395990 A IL9395990 A IL 9395990A IL 93959 A0 IL93959 A0 IL 93959A0
Authority
IL
Israel
Prior art keywords
antibiotic
biologically active
peptide
pharmaceutical compositions
active peptides
Prior art date
Application number
IL93959A
Other languages
English (en)
Original Assignee
Magainin Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Sciences Inc filed Critical Magainin Sciences Inc
Publication of IL93959A0 publication Critical patent/IL93959A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL93959A 1989-04-17 1990-03-30 Pharmaceutical compositions comprising biologically active peptides and an antibiotic IL93959A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33929289A 1989-04-17 1989-04-17
US07/402,642 US5254535A (en) 1989-04-17 1989-09-05 Composition and treatment with biologically active peptides and antibiotic

Publications (1)

Publication Number Publication Date
IL93959A0 true IL93959A0 (en) 1990-12-23

Family

ID=26991557

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93959A IL93959A0 (en) 1989-04-17 1990-03-30 Pharmaceutical compositions comprising biologically active peptides and an antibiotic

Country Status (12)

Country Link
US (1) US5254535A (fr)
EP (1) EP0469036B1 (fr)
JP (1) JPH04507087A (fr)
KR (1) KR920700042A (fr)
CN (1) CN1046462A (fr)
AT (1) ATE135230T1 (fr)
AU (1) AU5439490A (fr)
CA (1) CA2013738A1 (fr)
DE (1) DE69025927T2 (fr)
DK (1) DK0469036T3 (fr)
IL (1) IL93959A0 (fr)
WO (1) WO1990012587A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
AU6251594A (en) * 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Treatment of cancerous growths with biologically active peptides and protease inhibitors
AU7050294A (en) * 1993-06-04 1995-01-03 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
JP3860838B2 (ja) 1995-08-23 2006-12-20 ユニバーシティー オブ ブリティッシュ コロンビア 抗微生物性陽イオン性ペプチドおよびそのスクリーニング方法
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
US20040072815A1 (en) * 2002-02-12 2004-04-15 Koppel Gary A. Antibiotic composition and method
EP1360961A1 (fr) * 2002-05-07 2003-11-12 AM-Pharma B.V. Utilisation de peptides antibiotiques pour potentialiser l'activité des agents antimicrobiens
US8293700B2 (en) 2003-08-14 2012-10-23 Cellectis Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
FR2858772A1 (fr) * 2003-08-14 2005-02-18 Diatos Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
WO2010075416A1 (fr) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Compositions antibiotiques destinées au traitement d'infections à gram négatif
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
GB201616014D0 (en) * 2016-09-20 2016-11-02 Helperby Therapeutics Ltd Combination
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN114432428A (zh) * 2022-02-24 2022-05-06 西北农林科技大学 PGLa提高细菌对抗生素的敏感性和延缓细菌耐药性产生的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
EP0209061B1 (fr) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Peptides à activité anticoagulante, leur procédé de préparation, d'obtention, leur application et les agents les contenant
AU609118B2 (en) * 1987-03-04 1991-04-26 United States of America, as represented by the Secretary, U.S. Department of Commerce, The New synthetic bioactive compounds and method of producing bioactive effect

Also Published As

Publication number Publication date
DK0469036T3 (da) 1996-04-01
AU5439490A (en) 1990-11-16
ATE135230T1 (de) 1996-03-15
EP0469036A1 (fr) 1992-02-05
DE69025927T2 (de) 1996-08-01
US5254535A (en) 1993-10-19
EP0469036A4 (en) 1992-07-08
EP0469036B1 (fr) 1996-03-13
DE69025927D1 (de) 1996-04-18
KR920700042A (ko) 1992-02-19
JPH04507087A (ja) 1992-12-10
CA2013738A1 (fr) 1990-10-17
CN1046462A (zh) 1990-10-31
WO1990012587A1 (fr) 1990-11-01

Similar Documents

Publication Publication Date Title
IL93959A0 (en) Pharmaceutical compositions comprising biologically active peptides and an antibiotic
ES2020738A6 (es) Composiciones farmaceuticas comprendiendo ciclosporinas.
CA2258920A1 (fr) Acide hyaluronique autoreticule et compositions pharmaceutiques associees pour le traitement des arthropathies
ZA895121B (en) Fr901228 substance and preparation thereof
ATE218580T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
EP0695759A3 (fr) Esters méthyliques d'un pentapeptide, qui inhibent le cancer humain
AU2845599A (en) Pharmaceutical compositions and their use
ATE92080T1 (de) Isolierung und strukturbestimmung des zytostatischen linearen depsipeptids dolastatin 15.
DE69713152D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
DK0521994T3 (da) Farmaceutiske formuleringer
CA2360220A1 (fr) Composes a base d'oxadiazole et compositions destinees a l'apport d'agents actifs
MY103769A (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients
AU2412695A (en) Taxane class derivative based pharmaceutical compositions
IL109161A0 (en) Amino alcohol derivatives, methods for the preparation thereof, and pharmaceutical compositions containing the same
AU6001494A (en) Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances
WO1999047101A3 (fr) Compositions contenant des acides lysophosphatidiques qui inhibent l'apoptose et leurs utilisations
IL111928A (en) Long acting poorly soluble salts of peptides and pharmaceutical compositions containing them
ATE148890T1 (de) Cyclische peptide mit substance p-und substance k-antagonistischer aktivität
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
EP0354714A3 (fr) Compositions pharmaceutiques renfermant des composés polyaromatiques
AU4410989A (en) Cpf peptide compositions and uses
EP0326067A3 (fr) Utilisation de cyclophyline comme agent anti-inflammatoire et immunomodulateur
PT93684A (pt) Processo de composicao e tratamento com peptidios biologicamente activos e antibioticos
IE890747L (en) Peptides with pharmaceutical activity
as Therapeutic Joint Meeting Parenteral Drug Association (USA)/Parenteral Society, Heathrow, UK (Contact: MG Powell, 6 Frankton Gardens, Stratton St. Margaret, Swindon, Wilts. SN3 4LU, UK Tel.:(0793) 824 254.)